18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy. (2020)
Attributed to:
Quatitative proteomic analysis of castrate-resistant prostate cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13550-020-00728-9
PubMed Identifier: 33237350
Publication URI: http://europepmc.org/abstract/MED/33237350
Type: Journal Article/Review
Volume: 10
Parent Publication: EJNMMI research
Issue: 1
ISSN: 2191-219X